Head-to-head · Cost-Efficiency Index
GobyMeds vs Livea
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
GobyMeds
Shoppers comfortable prepaying a 3-month bundle upfront to get the lowest advertised compounded GLP-1 rate.
Visit GobyMedsLivea
Cost-first shoppers who want mN/WI residents wanting in-person clinic access, or telehealth patients in MN, WI, IA, or FL.
Visit LiveaThe verdict
GobyMeds and Livea tie on the Cost-Efficiency Index at 62/100, so neither wins outright on the numbers. For most shoppers we'd start with GobyMeds (ranked #207, a hair above #208) — Shoppers comfortable prepaying a 3-month bundle upfront to get the lowest advertised compounded GLP-1 rate. But Livea is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs GobyMeds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | GobyMeds | Livea |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 62/100 |
| Semaglutide / mo | $99/mo (starting dose, 3-month plan, compounded) | $99/mo (starting dose, compounded) |
| Tirzepatide / mo | $133/mo (starting dose, 3-month plan, compounded) | $199/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $1,188 |
| Tirzepatide / yr (modeled) | $1,596 | $2,388 |
| Coverage | Coverage not published | 4 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #207 | #208 |
GobyMeds
62/100Where the value is
- Available in all 50 states per the site's own copy
- No membership fees, free shipping, and HSA/FSA accepted
- Transparent tiered pricing published before intake, including how bundle cost rises with dose reached
The tradeoffs
- The $99/$133 headline requires prepaying the full 3-month bundle ($299/$399); paying monthly costs $169/$299 instead — 71% to 125% more
- Compounding pharmacy is not named, only described as 'GobyMeds' 503A or 503B pharmacy partner'
Livea
62/100Where the value is
- Hybrid model offers real in-person clinic locations (8 across MN & WI), not telehealth-only
- Low headline starting price for semaglutide ($99/mo)
- Broader wellness service menu (nutrition, hormone therapy, NAD+) beyond just GLP-1s
The tradeoffs
- Tirzepatide explicitly flagged 'when available,' implying inconsistent supply
- No named medical director or specific compounding pharmacy partner
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.